NLRP3 and Parkinson disease: There are also reports in the literature that ECH improves the neuropathological state of PD mice through neuroprotective cell survival and inhibiting activated microglia-mediated NLRP3/CASP-1/IL-1β inflammation signals (Gao et al., 2020).